S&P 500   3,001.53 (+0.18%)
DOW   26,860.86 (+0.27%)
QQQ   192.13 (+0.15%)
AAPL   242.46 (+1.04%)
FB   186.20 (+2.12%)
MSFT   136.24 (-0.10%)
AMZN   1,767.03 (+0.07%)
CGC   21.22 (+0.33%)
NVDA   194.82 (-0.40%)
BABA   169.95 (+0.04%)
GE   9.04 (-0.22%)
TSLA   254.85 (-0.29%)
AMD   31.43 (-0.25%)
ACB   3.63 (+1.40%)
NFLX   272.70 (+2.25%)
BAC   31.29 (+0.29%)
GILD   66.10 (+0.36%)
DIS   131.56 (-0.63%)
S&P 500   3,001.53 (+0.18%)
DOW   26,860.86 (+0.27%)
QQQ   192.13 (+0.15%)
AAPL   242.46 (+1.04%)
FB   186.20 (+2.12%)
MSFT   136.24 (-0.10%)
AMZN   1,767.03 (+0.07%)
CGC   21.22 (+0.33%)
NVDA   194.82 (-0.40%)
BABA   169.95 (+0.04%)
GE   9.04 (-0.22%)
TSLA   254.85 (-0.29%)
AMD   31.43 (-0.25%)
ACB   3.63 (+1.40%)
NFLX   272.70 (+2.25%)
BAC   31.29 (+0.29%)
GILD   66.10 (+0.36%)
DIS   131.56 (-0.63%)
Log in

Epizyme SEC Filings & 10K Form (NASDAQ:EPZM)

$10.79
-0.05 (-0.46 %)
(As of 10/23/2019 11:36 AM ET)
Today's Range
$10.71
Now: $10.79
$10.84
50-Day Range
$9.85
MA: $11.15
$13.35
52-Week Range
$5.14
Now: $10.79
$16.59
Volume46,136 shs
Average Volume513,032 shs
Market Capitalization$982.32 million
P/E RatioN/A
Dividend YieldN/A
Beta2.37

SEC Filings

Epizyme (NASDAQ:EPZM) SEC Filings

DateFilerForm TypeView
10/02/2019
3:54 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:15 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:46 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4/A
09/04/2019
7:35 PM
Bogle Grant C. (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
7:32 PM
Epizyme (Issuer)
Richon Victoria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
7:32 PM
Bogle Grant C. (Reporting)
Epizyme (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2019
7:28 PM
Epizyme (Issuer)
Richon Victoria (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2019
3:16 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2019
5:06 AM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
5:05 AM
Epizyme (Issuer)
TOMBESI PAOLO (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/19/2019
3:42 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
5:46 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
5:34 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
3:01 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2019
3:10 PM
Epizyme (Subject)
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Form SC 13D/A
07/02/2019
3:15 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
6:05 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
4:16 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:18 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:56 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:55 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:54 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
5:53 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:44 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:29 PM
Epizyme (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:28 PM
Epizyme (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:28 PM
BATE KENNETH (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:26 PM
Allen Andrew R (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:25 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:25 PM
Epizyme (Issuer)
Giordano Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:24 PM
Epizyme (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
3:13 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
5:46 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
5:39 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
5:17 AM
Epizyme (Filer)
Form DEFA14A
04/18/2019
5:15 AM
Epizyme (Filer)
Form DEF 14A
03/19/2019
7:10 AM
Epizyme (Filer)
Form CT ORDER
03/07/2019
3:22 PM
Epizyme (Filer)
Form 424B5
03/07/2019
3:19 PM
Epizyme (Filer)
Form 424B5
03/07/2019
3:12 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
4:28 PM
Epizyme (Filer)
Form 424B5
03/06/2019
4:28 PM
Epizyme (Filer)
Form 424B5
02/26/2019
5:46 AM
Epizyme (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2019
5:34 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
10:52 AM
Epizyme (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/11/2019
8:26 AM
Epizyme (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
2:57 PM
Epizyme (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
02/04/2019
3:43 PM
BlackRock Inc. (Filed by)
Epizyme (Subject)
Form SC 13G/A
01/28/2019
7:18 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
7:18 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
7:14 PM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
7:14 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
7:54 PM
Beaulieu Joseph (Reporting)
Epizyme (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/17/2019
3:07 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
5:39 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2018
5:36 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
5:30 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
5:05 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2018
9:04 AM
Epizyme (Subject)
FMR LLC (Filed by)
Form SC 13G/A
10/05/2018
5:36 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
3:49 PM
Epizyme (Filer)
Form 424B5
10/03/2018
8:21 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2018
3:02 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
6:32 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
7:52 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
6:31 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2018
11:46 AM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2018
11:32 AM
Agarwal Shefali (Reporting)
Epizyme (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2018
4:42 PM
Epizyme (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
4:37 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
4:34 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
4:11 PM
Epizyme (Filer)
Form CT ORDER
05/31/2018
3:29 PM
Epizyme (Issuer)
MOTT DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
3:28 PM
Allen Andrew R (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
3:27 PM
Epizyme (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
3:26 PM
Epizyme (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
3:25 PM
BATE KENNETH (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
3:24 PM
Epizyme (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
3:23 PM
Conroy Kevin T (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2018
1:31 PM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
6:16 AM
Epizyme (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/05/2018
3:34 PM
Epizyme (Filer)
Form S-3ASR
04/05/2018
3:29 PM
Epizyme (Filer)
Form DEFA14A
04/05/2018
3:25 PM
Epizyme (Filer)
Form DEF 14A
03/13/2018
5:51 AM
Epizyme (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2018
5:31 AM
Epizyme (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2018
3:53 PM
Epizyme (Issuer)
Giordano Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2018
3:50 PM
Epizyme (Issuer)
Giordano Michael F (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2018
5:20 AM
Epizyme (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
02/13/2018
4:08 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2018
4:05 PM
Epizyme (Issuer)
Graf Susan E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2018
4:04 PM
Bazemore Robert B (Reporting)
Epizyme (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2018
8:35 AM
Epizyme (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2018
3:26 PM
Epizyme (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2018
7:01 AM
Epizyme (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Featured Article: What is basic economics?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel